Mynd life sciences announces the issuance of 4,000,001 shares at $0.71/share

Vancouver, british columbia--(newsfile corp. - january 17, 2025) - mynd life sciences (cse: mynd) (otc pink: myndf) ("mynd" or the "company") a clinical-stage life sciences company committed to the development and commercialization of drug therapies and diagnostics to improve the monitoring and treatment of depression, today announced that the board has approved the issuance of 4,000,001 common shares at $0.71/share in relation to the settlement of the $3.5 million (cdn) of debenture announced on january 10, 2025. "we are pleased to announce that instructions to issue 4,000,001 shares for a total value of $2,840,000.71 in settlement of the debenture has been completed.
MYND Ratings Summary
MYND Quant Ranking